1. Malignancy-associated dermatomyositis: Retrospective case–control study from a single tertiary care center 
Laura Kooistra, BS, Claudia Ricotti, BS, Fabrizio Galimberti, MD, Carmen Gota, MD, Anthony P. Fernandez, MD, PhD 
Journal of the American Academy of Dermatology 
Volume 79, Issue 1, Pages (July 2018)
DOI: /j.jaad
Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions

2. Fig 1
Patients with malignancies diagnosed within 3 years of DM diagnosis, Of 73 malignancy-associated DM patients (excluding common, nonmelanoma skin cancer), 50 (68.5%) developed malignancy within 3 years of DM diagnosis. Malignancy distribution of 50 patients: 9 lung, 7 colon, 6 breast, 5 hematologic, 4 oropharyngeal, 4 ovarian, 4 renal, 3 thyroid, 2 esophageal, 2 prostate, 1 thymic, 1 melanoma, 1 gastric, and 1 testicular. DM, Dermatomyositis.
Journal of the American Academy of Dermatology  , DOI: ( /j.jaad )
Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions